251 related articles for article (PubMed ID: 23763844)
1. Cost-effectiveness of continuous-flow left ventricular assist devices.
Neyt M; Van den Bruel A; Smit Y; De Jonge N; Erasmus M; Van Dijk D; Vlayen J
Int J Technol Assess Health Care; 2013 Jul; 29(3):254-60. PubMed ID: 23763844
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy.
Rogers JG; Bostic RR; Tong KB; Adamson R; Russo M; Slaughter MS
Circ Heart Fail; 2012 Jan; 5(1):10-6. PubMed ID: 22052901
[TBL] [Abstract][Full Text] [Related]
3. Left Ventricular Assist Devices for Destination Therapy: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2016; 16(3):1-60. PubMed ID: 27026798
[TBL] [Abstract][Full Text] [Related]
4. Economic Evaluation of Left Ventricular Assist Devices for Patients With End Stage Heart Failure Who Are Ineligible for Cardiac Transplantation.
Chew DS; Manns B; Miller RJH; Sharma N; Exner DV
Can J Cardiol; 2017 Oct; 33(10):1283-1291. PubMed ID: 28941608
[TBL] [Abstract][Full Text] [Related]
5. The cost-utility of left ventricular assist devices for end-stage heart failure patients ineligible for cardiac transplantation: a systematic review and critical appraisal of economic evaluations.
Neyt M; Van den Bruel A; Smit Y; De Jonge N; Vlayen J
Ann Cardiothorac Surg; 2014 Sep; 3(5):439-49. PubMed ID: 25452904
[TBL] [Abstract][Full Text] [Related]
6. Comparative survival and cost-effectiveness of advanced therapies for end-stage heart failure.
Long EF; Swain GW; Mangi AA
Circ Heart Fail; 2014 May; 7(3):470-8. PubMed ID: 24563450
[TBL] [Abstract][Full Text] [Related]
7. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.
Clegg AJ; Scott DA; Loveman E; Colquitt J; Hutchinson J; Royle P; Bryant J
Health Technol Assess; 2005 Nov; 9(45):1-132, iii-iv. PubMed ID: 16303098
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of the implantable HeartMate II left ventricular assist device for patients awaiting heart transplantation.
Moreno SG; Novielli N; Cooper NJ
J Heart Lung Transplant; 2012 May; 31(5):450-8. PubMed ID: 22115674
[TBL] [Abstract][Full Text] [Related]
9. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
[TBL] [Abstract][Full Text] [Related]
10. Cost-Effectiveness of Left Ventricular Assist Devices in Ambulatory Patients With Advanced Heart Failure.
Baras Shreibati J; Goldhaber-Fiebert JD; Banerjee D; Owens DK; Hlatky MA
JACC Heart Fail; 2017 Feb; 5(2):110-119. PubMed ID: 28017351
[TBL] [Abstract][Full Text] [Related]
11. A clinical and cost-effectiveness analysis of the HeartMate 3 left ventricular assist device for transplant-ineligible patients: A United Kingdom perspective.
Lim HS; Shaw S; Carter AW; Jayawardana S; Mossialos E; Mehra MR
J Heart Lung Transplant; 2022 Feb; 41(2):174-186. PubMed ID: 34922821
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of left ventricular assist devices (LVADs) for patients with advanced heart failure: analysis of the British NHS bridge to transplant (BTT) program.
Clarke A; Pulikottil-Jacob R; Connock M; Suri G; Kandala NB; Maheswaran H; Banner NR; Sutcliffe P
Int J Cardiol; 2014 Feb; 171(3):338-45. PubMed ID: 24424339
[TBL] [Abstract][Full Text] [Related]
13. Neurocognitive function in destination therapy patients receiving continuous-flow vs pulsatile-flow left ventricular assist device support.
Petrucci RJ; Rogers JG; Blue L; Gallagher C; Russell SD; Dordunoo D; Jaski BE; Chillcott S; Sun B; Yanssens TL; Tatooles A; Koundakjian L; Farrar DJ; Slaughter MS
J Heart Lung Transplant; 2012 Jan; 31(1):27-36. PubMed ID: 22153550
[TBL] [Abstract][Full Text] [Related]
14. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
[TBL] [Abstract][Full Text] [Related]
15. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device.
Pagani FD; Miller LW; Russell SD; Aaronson KD; John R; Boyle AJ; Conte JV; Bogaev RC; MacGillivray TE; Naka Y; Mancini D; Massey HT; Chen L; Klodell CT; Aranda JM; Moazami N; Ewald GA; Farrar DJ; Frazier OH;
J Am Coll Cardiol; 2009 Jul; 54(4):312-21. PubMed ID: 19608028
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of left ventricular assist devices for patients with end-stage heart failure: analysis of the French hospital discharge database.
Tadmouri A; Blomkvist J; Landais C; Seymour J; Azmoun A
ESC Heart Fail; 2018 Feb; 5(1):75-86. PubMed ID: 28741873
[TBL] [Abstract][Full Text] [Related]
18. End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices.
Radovancevic B; Vrtovec B; de Kort E; Radovancevic R; Gregoric ID; Frazier OH
J Heart Lung Transplant; 2007 Aug; 26(8):815-8. PubMed ID: 17692785
[TBL] [Abstract][Full Text] [Related]
19. Long-term continuous flow left ventricular assist device support and end-organ function: prospects for destination therapy.
Slaughter MS
J Card Surg; 2010 Jul; 25(4):490-4. PubMed ID: 20642766
[TBL] [Abstract][Full Text] [Related]
20. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial.
Rogers JG; Butler J; Lansman SL; Gass A; Portner PM; Pasque MK; Pierson RN;
J Am Coll Cardiol; 2007 Aug; 50(8):741-7. PubMed ID: 17707178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
